Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folinic Acid in Children with Autism Spectrum Disorder
NCT03771560Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Feb 2018
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label trial of folinic acid in Autism Spectrum Disorder (ASD), sponsored by University of California, San Francisco. Primary endpoints: Aberrant Behavior Checklist - Parent Reported Change at 12 weeks and Aberrant Behavior Checklist - Teacher Reported Change at 12 weeks. Started Feb 2018; status: completed.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03771560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771560.